390 related articles for article (PubMed ID: 17363744)
21. In vivo administration of glucosamine inhibited phosphatidylinositol 3-kinase activity without affecting tyrosine phosphorylation of the insulin receptor or insulin receptor substrate in rat adipocytes.
Miki T; Sakaue M; Kasuga M
Kobe J Med Sci; 2002 Aug; 48(3-4):105-14. PubMed ID: 12502902
[TBL] [Abstract][Full Text] [Related]
22. Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice.
Bauche IB; Ait El Mkadem S; Rezsohazy R; Funahashi T; Maeda N; Miranda LM; Brichard SM
Biochem Biophys Res Commun; 2006 Jul; 345(4):1414-24. PubMed ID: 16729974
[TBL] [Abstract][Full Text] [Related]
23. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
[TBL] [Abstract][Full Text] [Related]
24. ATP-sensitive K+ channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling.
Minami K; Morita M; Saraya A; Yano H; Terauchi Y; Miki T; Kuriyama T; Kadowaki T; Seino S
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1289-96. PubMed ID: 12933351
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.
Yakar S; Setser J; Zhao H; Stannard B; Haluzik M; Glatt V; Bouxsein ML; Kopchick JJ; LeRoith D
J Clin Invest; 2004 Jan; 113(1):96-105. PubMed ID: 14702113
[TBL] [Abstract][Full Text] [Related]
26. [Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance].
Chu YL; Qiu HY; Sun YY; Li M; Li HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):455-8. PubMed ID: 17083810
[TBL] [Abstract][Full Text] [Related]
27. Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes.
Xu A; Wong LC; Wang Y; Xu JY; Cooper GJ; Lam KS
FEBS Lett; 2004 Aug; 572(1-3):129-34. PubMed ID: 15304336
[TBL] [Abstract][Full Text] [Related]
28. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes.
Lorenzo M; Fernández-Veledo S; Vila-Bedmar R; Garcia-Guerra L; De Alvaro C; Nieto-Vazquez I
J Anim Sci; 2008 Apr; 86(14 Suppl):E94-104. PubMed ID: 17940160
[TBL] [Abstract][Full Text] [Related]
29. Potential role of growth hormone in impairment of insulin signaling in skeletal muscle, adipose tissue, and liver of rats chronically treated with arginine.
de Castro Barbosa T; de Carvalho JE; Poyares LL; Bordin S; Machado UF; Nunes MT
Endocrinology; 2009 May; 150(5):2080-6. PubMed ID: 19106217
[TBL] [Abstract][Full Text] [Related]
30. Effects of growth hormone on glucose metabolism.
Møller N; Jørgensen JO; Abildgård N; Orskov L; Schmitz O; Christiansen JS
Horm Res; 1991; 36 Suppl 1():32-5. PubMed ID: 1806481
[TBL] [Abstract][Full Text] [Related]
31. The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids.
D'Eon TM; Pierce KA; Roix JJ; Tyler A; Chen H; Teixeira SR
Diabetes; 2008 May; 57(5):1262-8. PubMed ID: 18276766
[TBL] [Abstract][Full Text] [Related]
32. Reduction of PTP1B induces differential expression of PI3-kinase (p85alpha) isoforms.
Rondinone CM; Clampit J; Gum RJ; Zinker BA; Jirousek MR; Trevillyan JM
Biochem Biophys Res Commun; 2004 Oct; 323(2):652-9. PubMed ID: 15369800
[TBL] [Abstract][Full Text] [Related]
33. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
[TBL] [Abstract][Full Text] [Related]
34. IRS-3 mediates insulin-induced glucose uptake in differentiated IRS-2(-/-) brown adipocytes.
Escribano O; Arribas M; Valverde AM; Benito M
Mol Cell Endocrinol; 2007 Mar; 268(1-2):1-9. PubMed ID: 17316975
[TBL] [Abstract][Full Text] [Related]
35. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.
Santos SH; Fernandes LR; Mario EG; Ferreira AV; Pôrto LC; Alvarez-Leite JI; Botion LM; Bader M; Alenina N; Santos RA
Diabetes; 2008 Feb; 57(2):340-7. PubMed ID: 18025412
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.
Cho H; Black SC; Looper D; Shi M; Kelly-Sullivan D; Timofeevski S; Siegel K; Yu XH; McDonnell SR; Chen P; Yie J; Ogilvie KM; Fraser J; Briscoe CP
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1142-51. PubMed ID: 18728225
[TBL] [Abstract][Full Text] [Related]
37. Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity.
Flint DJ; Binart N; Boumard S; Kopchick JJ; Kelly P
J Endocrinol; 2006 Oct; 191(1):101-11. PubMed ID: 17065393
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated glutathione metabolism links to impaired insulin action in adipocytes.
Kobayashi H; Matsuda M; Fukuhara A; Komuro R; Shimomura I
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1326-34. PubMed ID: 19366877
[TBL] [Abstract][Full Text] [Related]
39. The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function.
Beeton CA; Das P; Waterfield MD; Shepherd PR
Mol Cell Biol Res Commun; 1999 May; 1(2):153-7. PubMed ID: 10356365
[TBL] [Abstract][Full Text] [Related]
40. SH3 domain of the phosphatidylinositol 3-kinase regulatory subunit is responsible for the formation of a sequestration complex with insulin receptor substrate-1.
Ikegami Y; Inukai K; Awata T; Asano T; Katayama S
Biochem Biophys Res Commun; 2008 Jan; 365(3):433-8. PubMed ID: 17991427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
